NCT00214552View on ClinicalTrials.gov

Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
AsthmaGastroesophageal Reflux Disease
Interventions
DRUG

rabeprazole

Trial Locations (2)

98105

ASTHMA, Inc., Seattle

99352

ASTHMA, Inc., Richland

Sponsors

Collaborators (1)

Janssen Pharmaceuticals
All Listed Sponsors
collaborator

Janssen Pharmaceuticals

INDUSTRY

collaborator

Eisai Inc.

INDUSTRY

lead

Associated Scientists to Help Minimize Allergies

OTHER